Azithromycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70860-100

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 70860-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Athenex Pharmaceutical Division, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azi02 0008 01

Chemical structure of azithromycin monohydrate, the active ingredient in Azithromycin injection powder for solution. The diagram shows the molecular arrangement with multiple rings, hydroxyl groups, and methyl substituents.*

FDA Label Image

Azi02 0008 02

Azithromycin for Injection, USP 500 mg per vial lyophilized powder for intravenous infusion only. The label states the product is sterile, nonpyrogenic, preservative-free, and contains azithromycin equivalent to 100 mg per mL after reconstitution. It is a single-dose vial manufactured by Athenex Pharmaceutical Division, LLC in Schaumburg, IL. Storage instructions include keeping the vial at controlled room temperature (20° to 25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.